Company profile for Tikomed

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We combine independent expertise in drug development with extensive business and scientific experience to navigate the complex pathway from lab to commercialisation. Our desire to drive scientific innovation is founded on a patient-centric vision, a clear business strategy, comprehensive product protection, and strong development partnerships. Our open information policy keeps our partners informed of our achievements while re...
We combine independent expertise in drug development with extensive business and scientific experience to navigate the complex pathway from lab to commercialisation. Our desire to drive scientific innovation is founded on a patient-centric vision, a clear business strategy, comprehensive product protection, and strong development partnerships. Our open information policy keeps our partners informed of our achievements while respecting the need for confidentiality.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Sweden
Address
Address
P.O. Box 81 263 03 Viken SWEDEN
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/tikomeds-drug-candidate-ilb-inhibited-infection-of-human-cells-by-dengue-zika-and-yellow-fever-viruses-in-vitro-providing-further-support-for-its-broad-spectrum-mechanism-of-action-301618953.html

PRNEWSWIRE
07 Sep 2022

https://www.prnewswire.com/news-releases/tikomeds-ilb-mobilizes-and-modulates-key-growth-factors-that-trigger-a-cascade-of-neuroprotective-mechanisms-able-to-target-all-neuroinflammation-driven-diseases-including-als-301615277.html

PRNEWSWIRE
31 Aug 2022

https://www.prnewswire.com/news-releases/tikomed-and-iqvia-announce-a-strategic-collaboration-for-the-development-of-tikomeds-lead-drug-platform-candidate-ilb-301540762.html

PRNEWSWIRE
05 May 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty